Get started
AXSOME THERAPEUT. DL-0001AXSOME THERAPEUT. DL-0001AXSOME THERAPEUT. DL-0001

AXSOME THERAPEUT. DL-0001

No trades
See on Supercharts
Overview
Financials News Ideas Forecast

19X chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪3.25 B‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.92EUR
Net income (FY)
‪−216.75 M‬EUR
Revenue (FY)
‪245.17 M‬EUR
Shares float
‪38.96 M‬
Beta (1Y)
1.14

About Axsome Therapeutics, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Herriott Tabuteau
Website
axsome.com
Headquarters
New York
Employees (FY)
545
Founded
2012
FIGI
BBG00GHB1C67
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview contain AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange AXSOME THERAPEUT. DL-0001 stocks are traded under the ticker 19X.
We've gathered analysts' opinions on AXSOME THERAPEUT. DL-0001 future price: according to them, 19X price has a max estimate of 176.69 EUR and a min estimate of 90.20 EUR. Watch 19X chart and read a more detailed AXSOME THERAPEUT. DL-0001 stock forecast: see what analysts think of AXSOME THERAPEUT. DL-0001 and suggest that you do with its stocks.
19X reached its all-time high on Apr 27, 2020 with the price of 114.00 EUR, and its all-time low was 1.72 EUR and was reached on Dec 28, 2018. View more price dynamics on 19X chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track AXSOME THERAPEUT. DL-0001 financials in yearly and quarterly reports right on TradingView.
AXSOME THERAPEUT. DL-0001 is going to release the next earnings report on Aug 5, 2024. Keep track of upcoming events with our Earnings Calendar.
19X earnings for the last quarter are −1.33 EUR per share, whereas the estimation was −1.12 EUR resulting in a −19.55% surprise. The estimated earnings for the next quarter are −1.20 EUR per share. See more details about AXSOME THERAPEUT. DL-0001 earnings.
AXSOME THERAPEUT. DL-0001 revenue for the last quarter amounts to ‪69.51 M‬ EUR despite the estimated figure of ‪67.92 M‬ EUR. In the next quarter revenue is expected to reach ‪80.17 M‬ EUR.
19X net income for the last quarter is ‪−63.35 M‬ EUR, while the quarter before that showed ‪−89.38 M‬ EUR of net income which accounts for 29.12% change. Track more AXSOME THERAPEUT. DL-0001 financial stats to get the full picture.
No, 19X doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 1, 2024, the company has 545.00 employees. See our rating of the largest employees — is AXSOME THERAPEUT. DL-0001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AXSOME THERAPEUT. DL-0001 EBITDA is ‪−219.88 M‬ EUR, and current EBITDA margin is −65.07%. See more stats in AXSOME THERAPEUT. DL-0001 financial statements.
Like other stocks, 19X shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AXSOME THERAPEUT. DL-0001 stock right from TradingView charts — choose your broker and connect to your account.